Is Adlai Nortye Ltd. (ANL) a Buy, Sell, or Hold?
NASDAQ : ANL
Adlai Nortye Ltd.
$11.3419 USD
-$0.01 (-0.07%)
- Volume
- 387.84K
- Average Volume
- 270.88K
- Market Capitalization
- $602.03M
- P/E Ratio
- -7.00
- Dividend Yield
- 0.00%
- Price Target
- $26.00
- Year High
- $17.25
- Year Low
- $0.88
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.65
| Source | Headline |
|---|---|
|
Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025
First patient dosed in intermittent QW dosing arm with AN9025 Intermittent dosing offers a differentiated approach in the pan-RAS(ON) inhibitor space and may widen the therapeutic window based on preclinical data Both QD and QW arms are now enrolling SINGAPORE and NORTH BRUNSWICK, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. globenewswire.com - 2026-07-16 07:00:00 |
|
Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists
SINGAPORE and NORTH BRUNSWICK, N.J., July 13, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (“Adlai Nortye” or the “Company”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced the expansion of its Scientific Advisory Board (SAB) with the appointments of two leading medical oncologists, Dr. David S. Hong and Dr. Piro Lito. globenewswire.com - 2026-07-13 07:00:00 |
|
Adlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's What You Should Know
Adlai Nortye Ltd. Sponsored ADR (ANL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. zacks.com - 2026-05-20 13:01:16 |
|
Here's Why Adlai Nortye Ltd. Sponsored ADR (ANL) Is a Great 'Buy the Bottom' Stock Now
Adlai Nortye Ltd. Sponsored ADR (ANL) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. zacks.com - 2026-05-11 10:56:18 |
|
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
Here is how ANI Pharmaceuticals (ANIP) and Adlai Nortye Ltd. Sponsored ADR (ANL) have performed compared to their sector so far this year. zacks.com - 2026-04-28 10:43:36 |
